These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15371871)

  • 1. Some pitfalls in pathological staging of invasive urothelial carcinoma.
    MacLennan GT; Taylor JM
    J Urol; 2004 Oct; 172(4 Pt 1):1464. PubMed ID: 15371871
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and substaging of pT1 bladder cancer].
    Cheng L; Huang WB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comments on the contribution by S. Presse et al. Morphology of bladder cancer based on cystectomy specimen].
    Mikuz G
    Pathologe; 1994 Feb; 15(1):63-4. PubMed ID: 8153080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Schilling D; Gakis G; Sievert KD; Stenzl A
    Aktuelle Urol; 2015 Jan; 46(1):72-81. PubMed ID: 25658234
    [No Abstract]   [Full Text] [Related]  

  • 5. [International Consensus Panel--treatment strategies for superficial bladder cancer].
    Adler S; St Niclas M
    Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous rupture of a bladder with invasive bladder carcinoma.
    Atalay AC; Karaman MI
    Int Urol Nephrol; 1998; 30(6):723-4. PubMed ID: 10195867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology of bladder cancer with reference to cystectomy specimen].
    Presse S; Savvas V; Kuntz RM
    Pathologe; 1993 Sep; 14(5):253-9. PubMed ID: 8415434
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
    Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
    Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    Zaghloul MS
    J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
    Chang BS; Kim HL; Yang XJ; Steinberg GD
    Urology; 2001 Jun; 57(6):1063-6; discussion 1066-7. PubMed ID: 11377305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
    Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade T1 bladder cancer at the ureterovesical junction.
    Soloway M
    Curr Urol Rep; 2007 Mar; 8(2):104-7. PubMed ID: 17303014
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 17. Radical cystectomy for stage T3b bladder cancer.
    Hall CM; Dinney CP
    Semin Urol Oncol; 1996 May; 14(2):73-80. PubMed ID: 8734734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk populations and cystectomy outcomes.
    Svatek RS; Avritscher EB; Elting L; Dinney CP
    J Urol; 2009 Jul; 182(1):10-1. PubMed ID: 19450857
    [No Abstract]   [Full Text] [Related]  

  • 20. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.